A new study links the popular weight loss drug Meridia to an increased risk of heart attacks and stroke. According to the authors of the trial, which was funded by Meridia's maker, the findings are generally in line with what was already known about the drug.
Since January, Meridia has carried a label warning that it should not be used by people with preexisting heart disease.
Business Week reports:
“ The U.S. Food and Drug Administration is slated to meet in September to decide if more regulatory action -- perhaps a tougher ‘black-box’ warning or even removing Meridia from the market -- should be taken ... The drug did not seem to make people healthier ... Some people were actually made worse”.